Login

PledPharma CEO, Nicklas Westerholm 00:00:00

Share On Facebook Share On Twitter

PledPharma / Pareto Securities’ 11th Annual Healthcare Conference

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
John A. Moore: CEO of ACORN Energy, Inc. | Jan Loeb, CEO, Acorn Energy IncACFN:QBB
00:10:00
Capital Raise Success and Expansion Plans: Insights from a Leading Public Mexican Issuer | Jorge Avalos Carpinteyro, CEO, Fibra Mty SAPI de CV.
00:10:00
Strategic Growth Through Acquisition: Expanding Our Technological Horizons|TIFFANY DUNSDON,Chief Executive Officer,Adapt IT Holdings Ltd
00:10:00
Nicholas Eberstadt on Political Economy and 'Men Without Work|Nicholas Eberstadt,Professor,American Enterprise Institute
00:10:00
New Year Market Volatility: Understanding the Causes and What to Do About It | Ben Smith, Founder, Cove Financial Planning.
00:10:00
Aspire Mining: Mongolian Coking Coal Developer with Significant Projects
00:10:00
France's Business Environment, Market Outlook, and Growth Strategy
00:10:00
Sustainability Commitment: A Call for Collaboration | Jose Ignacio Escobar, CEO, Colbun SA.
00:00:00
4D Pharma finds success for its Parkinson’s treatment - Duncan Peyton, CEO, 4D Pharma
00:10:00
Crayon's Role in AI Innovation: A Focus on Responsible AI | Melissa Mulholland, Chief Executive Officer of crayon group holding asa
00:10:00
committed to developing next-generation precision diagnostics and exosome solutions|Dr Gregory Rice,Chief Scientific Officer,Sienna Cancer Diagnostics Ltd
00:10:00
Five Questions with Jan Bredack, CEO of Veganz Group AG | Jan Bredack, CEO , Veganz Group AG.

© 2017 - Neuhu+